OM Outset Medical, Inc.

Outset Medical, Inc. is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. Its Tablo® Hemodialysis System (Tablo) represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings. Tablo was designed from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.

$48.85  +1.20 (2.51%)
As of 03/08/2021 11:11:32 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Medical Devices
USA
USA
09/15/2020
42,700,611
176,316
$2,034,684,114
0.00%
SEC Edgar Online
10-Q
10-K
690145107
US6901451079
BMGWSL0

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-34.51
5.74
28.55
-21.77%
-328.67%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy